SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-18-009979
Filing Date
2018-07-13
Accepted
2018-07-13 16:23:15
Documents
103
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 2457391
2 ex23-1.htm EX-23.1 3348
3 ex31-1.htm EX-31.1 19141
4 ex31-2.htm EX-31.2 11314
5 ex32-1.htm EX-32.1 4836
6 ex32-2.htm EX-32.2 4795
  Complete submission text file 0001493152-18-009979.txt   7777074

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE aker-20171231.xml EX-101.INS 1159764
8 XBRL SCHEMA FILE aker-20171231.xsd EX-101.SCH 75458
9 XBRL CALCULATION FILE aker-20171231_cal.xml EX-101.CAL 79742
10 XBRL DEFINITION FILE aker-20171231_def.xml EX-101.DEF 324800
11 XBRL LABEL FILE aker-20171231_lab.xml EX-101.LAB 512548
12 XBRL PRESENTATION FILE aker-20171231_pre.xml EX-101.PRE 454782
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36268 | Film No.: 18952728
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1